Autoantibodies in myasthenia gravis: cluster analysis and clinical correlations
Overall, cluster 2 features were less favorable to patients. This study provides valuable insights into the clinical and autoantibody profiles of Chinese MG patients.
Authors
- Hua Yue (ORCID: https://orcid.org/0000-0002-8413-7260)
- Xi Rong (ORCID: https://orcid.org/0000-0001-7234-3801)
- Xiaolin Sun (ORCID: https://orcid.org/0000-0001-9709-1532)
- Yunjun Yan (ORCID: https://orcid.org/0000-0001-6643-597X)
- Meijie Qu (ORCID: https://orcid.org/0000-0001-7942-5455)
- Min Liu (ORCID: https://orcid.org/0000-0003-4779-8489)
- Lin Liu (ORCID: https://orcid.org/0000-0002-7202-3418)
- Yichao Zhao (ORCID: https://orcid.org/0000-0002-1190-5396)
- Na Sun (ORCID: https://orcid.org/0009-0003-8388-8235)
- MingYue Lv
Institutions
- Qingdao University (CN)
- Affiliated Hospital of Qingdao University (CN)
- Dian Diagnostics (China) (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-02-04
- DOI
- https://doi.org/10.3389/fneur.2025.1537783
- Citations
- 2
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 2.78